This paper provides an overview of the use of matrix models within the context of Pharmacotherapy. It also discusses the application of these matrix models to the Safe Therapeutic Economic Pharmaceutical Selection (STEPS) approach used in Northern Ireland.
'Matrix models and STEPS: concluding remarks', Mike Scott, Mark Timoney, Jill Mairs, Grainne Crealey, Ibrahim Al Abaddi, Rob Brenninkmeijer, Rob Janknegt & James McElnay. In: Expert Opinion on Pharmacotherapy, October 2007, 8, suppl. 1, p.65-67